ATYPICAL FEMORAL FRACTURES AFTER TREATMENT WITH BISPHOSPHONATES AND DENOSUMAB IN INFLAMMATORY AND SENILE OSTEOPOROSIS

被引：1
|
作者：
Melendez, L. Merino [1 ]
Llorente, I. [1 ]
Garcia, E. [1 ]
Garcia-Vicuna, R. [1 ]
Sanz, S. Castaneda [1 ]
机构：
[1] Hosp Univ la Princesa, Rheumatol, Madrid, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.5000
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0288
引用
收藏
页码：762 / 763
页数：2
相关论文
共 50 条
  • [31] Atypical Femoral Fracture After the Withdrawal of Bisphosphonates
    Franekova, Lenka
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2022, 28 (04) : E675 - E676
  • [32] Denosumab/teriparatideRecurrent bilateral atypical femoral fractures: case report
    Reactions Weekly, 2016, 1590 (1) : 82 - 82
  • [33] Long-term safety of bisphosphonates: atypical femoral fractures
    Noguer-Martorell, M.
    Pellicer-Jacomet, M. A.
    Modamio, P.
    Nadal Llover, M.
    Lastra, C. F.
    Guerrero-Guerrero, A.
    Marino, E. L.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 967 - 968
  • [34] GGPS1 Mutation and Atypical Femoral Fractures with Bisphosphonates
    Roca-Ayats, Neus
    Balcells, Susana
    Garcia-Giralt, Natalia
    Falco-Mascaro, Maite
    Martinez-Gil, Nuria
    Abril, Josep F.
    Urreizti, Roser
    Dopazo, Joaquin
    Quesada-Gomez, Jose M.
    Nogues, Xavier
    Mellibovsky, Leonardo
    Prieto-Alhambra, Daniel
    Dunford, James E.
    Javaid, Muhammad K.
    Russell, R. Graham
    Grinberg, Daniel
    Diez-Perez, Adolfo
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (18): : 1794 - 1795
  • [35] Atypical Subtrochanteric and Femoral Shaft Fractures and Possible Association with Bisphosphonates
    Nieves J.W.
    Cosman F.
    Current Osteoporosis Reports, 2010, 8 (1) : 34 - 39
  • [36] ARE BISPHOSPHONATES SOLELY RESPONSIBLE FOR ATYPICAL FEMORAL FRACTURES? A CASE SERIES
    Jamal, M. S.
    Cockill, C.
    Knights, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 453 - 454
  • [37] Are Bisphosphonates Associated With an Increased Risk of Atypical Femoral Fractures as a Class?
    Pazianas, Michael
    JAMA INTERNAL MEDICINE, 2013, 173 (01) : 79 - 80
  • [38] Bisphosphonates/denosumab/ibandronic-acidAtypical femoral fractures: 3 case reports
    Reactions Weekly, 2022, 1931 (1) : 142 - 142
  • [39] Atypical femoral fracture in a bisphosphonate-naive patient on denosumab for osteoporosis
    Kumar, Shejil
    Chang, Ruby
    Reyes, Michael
    Diamond, Terrence
    ARCHIVES OF OSTEOPOROSIS, 2022, 17 (01)
  • [40] Prevention and treatment of senile osteoporosis and hip fractures
    Duque, G.
    Demontiero, O.
    Troen, B. R.
    MINERVA MEDICA, 2009, 100 (01) : 79 - 94
12345